* Enfusion Inc ENFN.N reported quarterly adjusted earnings
of 3
cents per share for the quarter ended in September. The mean
expectation of six analysts for the quarter was for earnings of
2 cents per share.
* Revenue rose 34.8% to $39.15 million from a year ago;
analysts
expected $38.54 million.
* Enfusion Inc's reported EPS for the quarter was 2 cents.
* The mean earnings estimate of analysts had fallen by
about 33.3%
in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Enfusion Inc shares had fallen by 0.8% this quarter and
lost 41.5% so far this year.
* The company reported quarterly net income of $1.54
million.
* Wall Street's median 12-month price target for Enfusion
Inc is
$13.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell."
This summary was machine generated from Refinitiv data November
11 at 12:48 a.m. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2022 0.02 0.03 Beat
Jun. 30 2022 0.02 0.06 Beat
Mar. 31 2022 0.03 0.07 Beat
Dec. 31 2021 0.04 0.02 Missed